EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mechanistic Insights into cardiac regeneration and protection through MEIS Inhibition

Aynura Mammadova iD, Galip Servet Aslan iD, Li Mo iD, Qifang Wu iD, Sebastian Clauss iD, Fatih Kocabaş iD

Turkish Journal of Biology · 20.12.2024 · 48 (6) · 414-431

DOI: 10.55730/1300-0152.2716 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Turkish Journal of Biology, online erschienen am 20.12.2024. Verfasst von Aynura Mammadova und 5 weiteren Autor:innen. Beteiligte Einrichtung: Regenerative Nanomedicine, INSERM-University of Strasbourg, Strasbourg, France. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

MEIS1, a member of the TALE-type homeobox gene family, has emerged as a pivotal regulator of cardiomyocyte cell cycle arrest and represents a promising therapeutic target. Our study reveals that inhibition of MEIS1 using two novel small molecules, MEISi-1 and MEISi-2, significantly enhances neonatal cardiomyocyte proliferation and cytokinesis. Specifically, MEISi-1 and MEISi-2 increased the proportion of proliferating cardiomyocytes (Ph3+TnnT cells) upto 4.5 fold and the percentage of cytokinetic cardiomyocytes (AuroraB+TnnT cells) by 2 fold, compared to untreated controls. MEIS1 inhibition resulted in a notable downregulation of MEIS1 target genes and cyclin-dependent kinase inhibitors, demonstrating its effect on key regulatory pathways. Additionally, the culture and differentiation of human induced pluripotent stem cells (hiPSCs) into cardiomyocytes were studied, with MEIS1 inhibition showing no adverse effects on cell viability. Extended treatment with MEIS inhibitors led to a substantial upregulation of critical cardiac-specific genes, including a 15-fold increase in the expression of Nkx2.5. This upregulation significantly impacted both cardiac mesoderm and cardiac progenitor cells. These findings underscore the potential of MEIS1 inhibitors as effective agents in enhancing cardiac regeneration and highlight their therapeutic promise in regenerative cardiology.

Schlagwörter

Stichwörter der Autor:innen

MEIS1cardiac protectioncardiac regenerationcardiomyocyte proliferation

Autor:innen und Institutionen

  • Regenerative Nanomedicine, INSERM-University of Strasbourg, Strasbourg, France.
  • Department of Genetics and Bioengineering, Faculty of Engineering, Yeditepe University, İstanbul, Turkiye.
  • Institute for Cardiovascular Regeneration, Goethe University, Frankfurt, Germany.
  • Department of Medicine I, University Hospital, LMU Munich, Munich, Germany.
  • German Center for Cardiovascular Research (DZHK), Partner Site Munich, Munich Heart Alliance, Munich, Germany.
  • Institute of Surgical Research at the Walter-Brendel-Centre of Experimental Medicine, University Hospital, LMU Munich, Munich, Germany.

ORCID-Profile: Aynura Mammadova, Galip Servet Aslan, Li Mo, Qifang Wu, Sebastian Clauss, Fatih Kocabaş

Zitieren

APA

Mammadova, A., Aslan, G. S., Mo, L., Wu, Q., Clauss, S., & Kocabaş, F. (2024). Mechanistic Insights into cardiac regeneration and protection through MEIS Inhibition. Turkish Journal of Biology, 48(6), 414-431. https://doi.org/10.55730/1300-0152.2716

Vancouver

Mammadova A, Aslan GS, Mo L, Wu Q, Clauss S, Kocabaş F. Mechanistic Insights into cardiac regeneration and protection through MEIS Inhibition. Turkish Journal of Biology. 2024;48(6):414-431. doi:10.55730/1300-0152.2716

BibTeX
@article{Mammadova2024,
  author = {Mammadova, Aynura and Aslan, Galip Servet and Mo, Li and Wu, Qifang and Clauss, Sebastian and Kocabaş, Fatih},
  title = {Mechanistic Insights into cardiac regeneration and protection through MEIS Inhibition},
  journal = {Turkish Journal of Biology},
  year = {2024},
  volume = {48},
  number = {6},
  pages = {414--431},
  doi = {10.55730/1300-0152.2716}
}
Kostenlos starten →